TransMedics Group Sees FY2026 Sales $727.000M-$757.000M vs $723.991M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
TransMedics Group (NASDAQ:TMDX) sees FY2026 sales of $727.000 million-$757.000 million vs $723.991 million analyst estimate.
TransMedics Group (NASDAQ:TMDX) sees FY2026 sales of $727.000 million-$757.000 million vs $723.991 million analyst estimate.